Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients.
about
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@ast
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@en
type
label
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@ast
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@en
prefLabel
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@ast
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@en
P2093
P2860
P356
P1433
P1476
Contribution of BCR-ABL kinase ...... nic myeloid leukemia patients.
@en
P2093
Abdul Aziz Baba
Abu Dzarr Abdullah
Azlan Husin
Goh Ai Sim
Marjanu Hikmah Elias
Ravindran Ankathil
Rosline Hassan
S Fadilah Abdul Wahid
P2860
P356
10.4081/HR.2012.E23
P577
2012-11-23T00:00:00Z